
CMX Cinemas got a Houston federal judge to pause a lawsuit claiming it’s using the coronavirus “as a pretext for walking away from” a deal to acquire a movie theater chain, a few days after it filed for Chapter 11 in a move the chain’s owner blasted as a bad-faith stunt.
Judge Andrew S. Hanen stayed the case indefinitely, noting in an order docketed Tuesday, April 28, that a bankruptcy petition automatically suspends other suits involving the filer, reported Bloomberg Law.
CMX parent Cinemex Holdings initiated Chapter 11 proceedings April 25 in the US Bankruptcy Court for the Southern District of Florida, then sought the same day to halt a lawsuit by Houston businessman Omar Khan asking the US District Court for the Southern District of Texas to keep their deal on track. A hearing had been set for April 27.
Hanen’s ruling came a day after Khan—owner of the 11-location Star Cinema Grill chain that Cinemex was set to buy—assailed that move, even as he acknowledged he saw no way around the automatic stay.
“Once it was clear that CMX’s delay tactics, ever-changing legal counsel, and posturing would not achieve its goal of pushing back the evidentiary hearing, CMX decided to use the US bankruptcy laws as a last resort,” he wrote April 27. “The timing of CMX’s bankruptcy itself is questionable, at best.”
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas